Home › Studies › PRJNA997572
PRJNA997572 SRP450970

Gut metagenome in T2DM patients on metformin, China

Research on the Mechanism of Metformin Improving Type 2 Diabetes

68 gut metagenome samples from newly diagnosed type 2 diabetes patients in China (Beijing), studying metformin drug therapy effects as part of an intervention design. machine-written summary

36 samples · 68 runs · CN · Age unknown · 2025 · 6.43 Gbp / sample

Sources
✓Sequence archive 216✓Abstract / description 72–Full text–Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive216 sample values (collection date, country, latitude, longitude, subject id, timepoint)
✓ Abstract / description72 sample values (health condition, health condition detail)
– Full textno open-access full text linked
– Supplementary tablesno supplementary tables available (or none open access)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Non-antibiotic pharmaceutical given as the study intervention (metformin design single_arm_before_after · population type2_diabetes · Metformin treatment in newly diagnosed T2DM patients

“effects of metformin on the transcriptome” — bioproject.description (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 sampling locations · 1 country
Age
unknown36
Condition
type2_diabetes36
Country
CN36
Body site
primary36
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 36 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 7.25 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal — not resolved

18 of 18 people sampled more than once (36 samples; median 2, up to 2 per person).

How longitudinal and relatedness information is derived

Community composition
Bacteroides 7.5%Bifidobacterium 7.5%Faecalibacterium 6.2%Prevotella 5.8%Blautia_A 5.5%Megamonas 5.4%Roseburia 5.2%Phocaeicola 5.0%Ruminococcoides 3.5%Escherichia 2.7%Enterococcus_B 2.7%Collinsella 2.3%not assigned to a genus 3.7%other genera 37.0%

Genera, mean relative abundance over 35 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category0 0%
country36 100%36
health_condition36 100%36
subject_id36 100%36
collection_date36 100%36
health_condition_detail36 100%36
latitude36 100%36
longitude36 100%36
timepoint_label36 100%36
Details
Archive description

In this study, we investigated the effects of metformin on the transcriptome data of whole blood samples and the metagenome data of the gut microbiota in newly diagnosed type 2 diabetes mellitus (T2DM) patients. Our objective was to identify potential mechanisms by which metformin treats T2DM.

How this project entered the registry

Classified as human and non-human (mixed) gut / stool shotgun DNA metagenome of age unknown by opus_adjudicated with confidence 0.50. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • host run.host_tax_id · “10090”
  • body site study.description · “metagenome data of the gut microbiota”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN36699553collection_date2023-05R10.90biosample.attribute:collection_date2023-05
SAMN36699553countryCNR10.90sample.attr.geo_loc_nameChina
SAMN36699553health_conditiontype2_diabetesR40.50study.descriptionnewly diagnosed type 2 diabetes mellitus (T2DM) patients
SAMN36699553health_condition_detailnewly diagnosed type 2 diabetes mellitusR40.50study.descriptionnewly diagnosed type 2 diabetes mellitus (T2DM)
SAMN36699553latitude38.2500R10.90biosample.attribute:lat_lon38.2500001 N 114.20 E
SAMN36699553longitude114.2000R10.90biosample.attribute:lat_lon38.2500001 N 114.20 E
SAMN36699553subject_id2R10.70sample.name_rule:aliasMS2_1_1
SAMN36699553timepoint_label1R10.70sample.name_rule:aliasMS2_1_1
Sequencing

68 runs over 36 samples · mean 3.87 Gbp per run (median 6.43 Gbp, total 263.29 Gbp; 68 runs with a base count) · layout PAIRED 36, SINGLE 32 · platform ILLUMINA 68 · models Illumina HiSeq X (36), Illumina HiSeq 2500 (32) · 51% of runs with a Sandpiper profile · first public 2025-12-18

Authors (0)

No author record.

Downloads

PRJNA997572.csv.gz (1.7 KB) · parquet (70.9 KB) — all 36 samples, every field with route and confidence · PRJNA997572_determinations.csv.gz (2.7 KB) — 288 evidence rows

Samples (36 · every field this project has values for · hover a cell for its source)
Loading the sample table…